Strengthen revenue performance and reduce risk—watch on-demand now!
As scrutiny intensifies across the healthcare sector, laboratories face increasing pressure from payer audits, reimbursement complexity, and consolidation activity. Staying ahead requires not only awareness, but informed action.
This collection of webinars with industry experts delivers practical guidance for laboratory executives, revenue cycle leaders, and compliance teams navigating payer policy changes, M&A activity, and molecular testing reimbursement.
🔬Labs Under the Microscope: Staying Ready for Payer Audits
Danielle Tangorre, Robinson+Cole
Ann Betzel, Quadax
History is a teacher. It's going to tell you what you're missing, what's wrong, how to fix it, and any proactiveness is key. It’s worth it in the long run to spend the time up front." - A. Betzel
Payer audits are no longer episodic—they’re expected. Medicare Targeted Probe and Educate (TPE) audits, UPIC reviews, and commercial pre-payment audits are increasing in frequency and sophistication. For laboratories focused on reducing audit risk and protecting cash flow, this session provides a clear, actionable audit-readiness framework grounded in real-world cases.
In this webinar:
- Common audit triggers that place labs on payer watchlists
- Key differences between prepayment and post-payment reviews
- Documentation and billing practices auditors scrutinize most
- Questions every lab should be asking its RCM partner
💼M&A Planning from a Legal, Market Access & RCM Perspective (Part 1)
Christal Contini, McDonald Hopkins
Elizabeth Sullivan, McDonald Hopkins
Abby Wright, Phaze4 Medical
Tom Cronin, Quadax
"The most successful labs have a strong partnership within the organization [with their RCM team]." - Tom Cronin
Successful laboratory acquisitions start long before contracts are signed. Part one of this two-part series focuses on pre-acquisition planning and risk assessment. This session is essential for lab executives evaluating growth, acquisition, or exit strategies who need a clear-eyed view of RCM and compliance risks before a deal moves forward.
In this webinar:
- Legal and regulatory considerations during due diligence
- Revenue cycle risks hidden in billing, payer contracts, and workflows
- Market access challenges that directly impact valuation
- Why cross-functional alignment—not just legal review—is critical
💼M&A Planning from a Legal, Market Access & RCM Perspective (Part 2)
Emily Johnson, McDonald Hopkins
Abby Wright, Phaze4 Medical
Patti Grey, Quadax
"Bringing your RCM partner into the discussions early will help you prepare for what might be coming their way. Think of additional transactional volume, additional resource needs."
- Patti Grey
Closing the deal is only the beginning. Part two shifts the focus to post-acquisition execution and integration, where operational missteps can quickly erode deal value. For laboratories navigating mergers or ownership transitions, this webinar delivers a disciplined approach to maintaining compliance, payer confidence, and revenue continuity during change.
In this webinar:
- Regulatory and payer notification requirements after ownership changes
- License transfers and accreditation considerations
- Data security, staff training, and operational alignment
- Key performance indicators to measure post-deal success
🔮The Future of Molecular Testing Reimbursement
Ann Lambrix, Lighthouse Lab Services
Tara Cepull, Quadax
"MolDx puts the onus on the front end to establish coverage, review clinical utility, and ensure established metrics." – Ann Lambrix
As molecular and genetic testing continues to expand, reimbursement complexity remains a significant barrier. Payer-specific utilization policies, MolDx rules, and prior authorization requirements can quickly disrupt payment. This session is ideal for labs performing advanced diagnostics that need clear guidance on staying compliant while securing accurate, timely reimbursement.
In this webinar:
- Current MolDx and payer reimbursement expectations
- Common reimbursement pitfalls for molecular testing
- Documentation and compliance strategies to reduce denials
- How labs can prepare for future reimbursement shifts
Stay Ahead with Expert-Led Laboratory Education
In an industry defined by constant change, informed leadership is a competitive advantage. Our webinar series provides ongoing access to trusted experts and actionable insights to help laboratories navigate regulatory shifts, reimbursement complexity, and consolidation with clarity and confidence.
Sign up to receive notifications about future webinars—and ensure your team stays prepared for what’s next in laboratory compliance, reimbursement, and revenue cycle performance.
